Literature DB >> 18332097

Retinal and cerebral microvascular signs and diabetes: the age, gene/environment susceptibility-Reykjavik study.

Chengxuan Qiu1, Mary Frances Cotch, Sigurdur Sigurdsson, Melissa Garcia, Ronald Klein, Fridbert Jonasson, Barbara E K Klein, Gudny Eiriksdottir, Tamara B Harris, Mark A van Buchem, Vilmundur Gudnason, Lenore J Launer.   

Abstract

OBJECTIVE: Diabetes increases the risk for microvascular disease. The retina and the brain both have intricate microvascular systems that are developmentally similar. We sought to examine whether microvascular lesions in the retina and in the brain are associated and whether this association differs among people with and without diabetes. RESEARCH DESIGN AND METHODS: The analysis included 4,218 participants of the Icelandic population-based Age, Gene/Environment Susceptibility-Reykjavik Study who were born in 1907-1935 and who were previously followed as a part of the Reykjavik Study. Retinal focal arteriolar narrowing, arteriovenous (AV) nicking, and microaneurysms/hemorrhages were evaluated on digital retinal images of both eyes. Cerebral microbleeds (CMBs) were evaluated from magnetic resonance images. Data were analyzed with logistic and multinomial logistic regression models controlling for demographics, major cardiovascular risk factors, cerebral infarcts, and white matter lesions.
RESULTS: Evidence of brain microbleeds was found in 485 (11.5%) people, including 192 with multiple (>or=2) microbleeds. Subjects with signs of retinal microvascular lesions were at a significantly increased likelihood for having multiple CMBs. People with diabetes in combination with the presence of either retinal AV nicking (odds ratio [OR] 2.47 [95% CI 1.42-4.31]) or retinal microaneurysms/hemorrhages (2.28 [1.24-4.18]) were significantly more likely to have multiple CMBs.
CONCLUSIONS: Retinal microvascular abnormalities and brain microbleeds may occur together in older adults. People with both diabetes and signs of retinal microvascular lesions (AV nicking and microaneurysms/hemorrhages) are more likely to have multiple microbleeds in the brain. Microvascular disease in diabetes extends to the brain.

Entities:  

Mesh:

Year:  2008        PMID: 18332097     DOI: 10.2337/db07-1455

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  46 in total

1.  Five-year incidence, progression, and risk factors for age-related macular degeneration: the age, gene/environment susceptibility study.

Authors:  Fridbert Jonasson; Diana E Fisher; Gudny Eiriksdottir; Sigurdur Sigurdsson; Ronald Klein; Lenore J Launer; Tamara Harris; Vilmundur Gudnason; Mary Frances Cotch
Journal:  Ophthalmology       Date:  2014-04-24       Impact factor: 12.079

2.  Cognitive function and retinal and ischemic brain changes: the Women's Health Initiative.

Authors:  M Haan; M A Espeland; B E Klein; R Casanova; S A Gaussoin; R D Jackson; A E Millen; S M Resnick; J E Rossouw; S A Shumaker; R Wallace; K Yaffe
Journal:  Neurology       Date:  2012-03-14       Impact factor: 9.910

3.  Middle-Aged Diabetic Females and Males Present Distinct Susceptibility to Alzheimer Disease-like Pathology.

Authors:  E Candeias; A I Duarte; I Sebastião; M A Fernandes; A I Plácido; C Carvalho; S Correia; R X Santos; R Seiça; M S Santos; C R Oliveira; P I Moreira
Journal:  Mol Neurobiol       Date:  2016-10-11       Impact factor: 5.590

4.  Lack of association between the MTHFR C677T variant and migraine with aura in an older population: could selective survival play a role?

Authors:  Ann I Scher; Gudny Eiriksdottir; Melissa Garcia; Preethy Feit; Albert V Smith; Tamara B Harris; Kathryn A Roecklein; Larus S Gudmundsson; Vilmundur Gudnason; Lenore J Launer
Journal:  Cephalalgia       Date:  2012-12-10       Impact factor: 6.292

Review 5.  Distribution of cerebral microbleeds in the East and West: Individual participant meta-analysis.

Authors:  Yusuke Yakushiji; Duncan Wilson; Gareth Ambler; Andreas Charidimou; Alexa Beiser; Mark A van Buchem; Charles DeCarli; Ding Ding; Villi Gudnason; Hideo Hara; Toshio Imaizumi; Katsuhiko Kohara; Hyung-Min Kwon; Lenore J Launer; Vincent Mok; Thanh Phan; Sarah R Preis; José Rafael Romero; Sudha Seshadri; Velandai Srikanth; Yuki Takashima; Yoshito Tsushima; Zhaolu Wang; Philip A Wolf; Yunyun Xiong; Shuhei Yamaguchi; David J Werring
Journal:  Neurology       Date:  2019-02-01       Impact factor: 9.910

Review 6.  Prediction of incident stroke events based on retinal vessel caliber: a systematic review and individual-participant meta-analysis.

Authors:  Kevin McGeechan; Gerald Liew; Petra Macaskill; Les Irwig; Ronald Klein; Barbara E K Klein; Jie Jin Wang; Paul Mitchell; Johannes R Vingerling; Paulus T V M de Jong; Jacqueline C M Witteman; Monique M B Breteler; Jonathan Shaw; Paul Zimmet; Tien Y Wong
Journal:  Am J Epidemiol       Date:  2009-11-01       Impact factor: 4.897

7.  Diabetic hyperglycemia aggravates seizures and status epilepticus-induced hippocampal damage.

Authors:  Chin-Wei Huang; Juei-Tang Cheng; Jing-Jane Tsai; Sheng-Nan Wu; Chao-Ching Huang
Journal:  Neurotox Res       Date:  2009-02-18       Impact factor: 3.911

Review 8.  Associations between retinal microvascular changes and dementia, cognitive functioning, and brain imaging abnormalities: a systematic review.

Authors:  Sophie M Heringa; Willem H Bouvy; Esther van den Berg; Annette C Moll; L Jaap Kappelle; Geert Jan Biessels
Journal:  J Cereb Blood Flow Metab       Date:  2013-04-17       Impact factor: 6.200

9.  A system for computerised retinal haemorrhage analysis.

Authors:  Tariq Aslam; Paul Chua; Matthew Richardson; Praveen Patel; Mohammed Musadiq
Journal:  BMC Res Notes       Date:  2009-09-28

10.  Aortic stiffness is associated with cardiac function and cerebral small vessel disease in patients with type 1 diabetes mellitus: assessment by magnetic resonance imaging.

Authors:  Saskia G C van Elderen; A Brandts; J J M Westenberg; J van der Grond; J T Tamsma; M A van Buchem; J A Romijn; L J M Kroft; J W A Smit; A de Roos
Journal:  Eur Radiol       Date:  2009-11-14       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.